Neuropsicofarmacología - GIC 21/128
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadoras/es de Instituto de Salud Carlos III (3)
2022
-
NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches
International Journal of Molecular Sciences, Vol. 23, Núm. 13
2019
-
Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics
Translational Psychiatry, Vol. 9, Núm. 1
2009
-
Cognitive performance and cigarette smoking in first-episode psychosis
European Archives of Psychiatry and Clinical Neuroscience, Vol. 259, Núm. 2, pp. 65-71